View in EDS HTML Full Text PDF Full Text

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

Saved in:
Bibliographic Details
Title: Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).
Authors: Halbherr, Stefan1 (AUTHOR), Lerch, Stefanie1,2 (AUTHOR), Bellwald, Sebastian3 (AUTHOR), Polakova, Petra1,4 (AUTHOR), Bannert, Bettina5 (AUTHOR), Roumet, Marie6 (AUTHOR), Charles, Roch-Philippe1,7 (AUTHOR), Walter, Martin A.8 (AUTHOR), Bernasconi, Corrado9 (AUTHOR), Halbherr, V. Lisa1 (AUTHOR), Peitsch, Camille1 (AUTHOR), Baumgartner, Pascal C.1 (AUTHOR), Kaufmann, Céline1 (AUTHOR), Aires, Vanessa1 (AUTHOR), Mattle, Heinrich P.10 (AUTHOR), Kaelin-Lang, Alain11,12 (AUTHOR), Hartmann, Andreas13 (AUTHOR), Schuepbach, Michael3 (AUTHOR) nik@hin.ch
Source: PLoS Medicine. 5/13/2025, Vol. 22 Issue 5, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15491277
DOI:10.1371/journal.pmed.1004472